Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28034012 | 1.00 | ALDH1A1 (0.33) | ALDH1A1LMNAHSD17B10THRBFNTA | |
| SCHEMBL22498781 | 0.75 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL1845480 | 0.75 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL291060 | 0.75 | FNTA (0.36) | ALDH1A1THRBFNTAFNTBPGGT1B | |
| SCHEMBL3847687 | 0.75 | FNTA (0.36) | ALDH1A1THRBFNTAFNTBPGGT1B | |
| Hydrogen Sulfide SCHEMBL8505278 | 0.74 | FNTA (0.35) | ALDH1A1THRBFNTAFNTBPGGT1B | |
| SCHEMBL28936366 | 0.72 | ALDH1A1 (0.36) | ALDH1A1LMNAHSD17B10 | |
| SCHEMBL27826180 | 0.72 | ALDH1A1 (0.41) | ALDH1A1LMNAHSD17B10THRB | |
| SCHEMBL28919867 | 0.70 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL29116352 | 0.69 | ALOX15 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117376-A1 | METHOD AND SYSTEM FOR FORMING A SILICON-CONTAINING LAYER AND STRUCTURE FORMED USING SAME | ASM IP HOLDING BV (NL) | 2026-04-30 | — | — | US | claimed |
| EP-4065616-A1 | POLYMER CONETWORKS OF POLY(PYRIDINE-(METH)-ACRYLAMIDE) DERIVATIVES-CROSSLINKED BY TRANSITION METAL IONS- AND LINKED BY POLYDIMETHYLSILOXANE DERIVATIVES | Luxembourg Institute of Science and Technology (LIST) (LU) | 2022-10-05 | — | — | EP | claimed |
| WO-2021105349-A1 | POLYMER CONETWORKS OF POLY(PYRIDINE-(METH)-ACRYLAMIDE) DERIVATIVES-CROSSLINKED BY TRANSITION METAL IONS- AND LINKED BY POLYDIMETHYLSILOXANE DERIVATIVES | LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY (LIST) (LU) | 2021-06-03 | — | — | WO | claimed |
| US-20200407270-A1 | TEXTURED GLASS ARTICLES AND METHODS OF MAKING THE SAME | CORNING INCORPORATED | 2020-12-31 | — | — | US | claimed |
| US-20260117376-A1 | METHOD AND SYSTEM FOR FORMING A SILICON-CONTAINING LAYER AND STRUCTURE FORMED USING SAME | ASM IP HOLDING BV (NL) | 2026-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117376-A1 | METHOD AND SYSTEM FOR FORMING A SILICON-CONTAINING LAYER AND STRUCTURE FORMED USING SAME | NOXO1, NOX3, TIE1 | ALDH1A1 4168/4885LMNA 1776/4885HSD17B10 3062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.